Related references
Note: Only part of the references are listed.Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma
Elena Zamagni et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
Laura Rosinol et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome (vol 105, pg 201, 2020)
Meral Beksac et al.
HAEMATOLOGICA (2021)
UPDATED RESULTS FROM THE CARTITUDE-1 STUDY OF CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
SZ Usmani et al.
Hematology Transfusion and Cell Therapy (2021)
Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease
Haobin Deng et al.
FRONTIERS IN IMMUNOLOGY (2021)
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs
Vittorio Montefusco et al.
HAEMATOLOGICA (2020)
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome
Meral Beksac et al.
HAEMATOLOGICA (2020)
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma
Ying Liu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis
Rafiye Ciftciler et al.
TURKISH JOURNAL OF HEMATOLOGY (2020)
Extramedullary Disease in Multiple Myeloma
Megan H. Jagosky et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2020)
Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease
Xiang Zhou et al.
CANCERS (2020)
HORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in 55 Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD)-Subgroup Analysis
Paul G. Richardson et al.
BLOOD (2020)
Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China
Baiyan Wang et al.
BLOOD (2020)
Extramedullary disease in multiple myeloma - controversies and future directions
Sabina Sevcikova et al.
BLOOD REVIEWS (2019)
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients
Irit Avivi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Nico Gagelmann et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Evaluation of the Prognostic Value of Positron Emission Tomography-Computed Tomography (PET-CT) at Diagnosis and Follow-up in Transplant-Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients Treated in the Phase 3 Cassiopeia Study: Results of the Cassiopet Companion Study
Philippe Moreau et al.
BLOOD (2019)
Leptomeningeal Myelomatosis: A Rare but Devastating Manifestation of Multiple Myeloma Diagnosed Using Cytology, Flow Cytometry, and Fluorescent in situ Hybridization
Martin Bommer et al.
ACTA HAEMATOLOGICA (2018)
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT
Nico Gagelmann et al.
HAEMATOLOGICA (2018)
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel
J. Caers et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT
Nico Gagelmann et al.
HAEMATOLOGICA (2018)
Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma
Talha Badar et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study
Philippe Moreau et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Michele Cavo et al.
LANCET ONCOLOGY (2017)
Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma
Khishigjargal Batsukh et al.
IMMUNE NETWORK (2017)
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice
Artur Jurczyszyn et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Myelomatous Involvement of the Central Nervous System
Jonas Paludo et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience
Eirini Katodritou et al.
ANNALS OF HEMATOLOGY (2015)
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation
Mathew Weinstock et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Features of Extramedullary Disease of Multiple Myeloma: High Frequency of P53 Deletion and Poor Survival: A Retrospective Single-Center Study of 834 Cases
Shuhui Deng et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Myeloma in Scar Tissue - An Underreported Phenomenon or an Emerging Entity in the Novel Agents' Era? A Single Center Series
Eli Muchtar et al.
ACTA HAEMATOLOGICA (2014)
Extramedullary Myeloma Spread Triggered by Surgical Procedures: An Emerging Entity?
Laura Rosinol et al.
ACTA HAEMATOLOGICA (2014)
The lymphoma-like polychemotherapy regimen Dexa-BEAM in advanced and extramedullary multiple myeloma
Leo Rasche et al.
ANNALS OF HEMATOLOGY (2014)
Patterns of Central Nervous System Involvement in Relapsed and Refractory Multiple Myeloma
Al-ola Abdallah et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2014)
Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse
Ludek Pour et al.
HAEMATOLOGICA (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Central nervous system multiple myeloma - potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains
Denise Lee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Cytogenetics of extramedullary manifestations in multiple myeloma
Lisa Billecke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents
Christine I. Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
C. Fernandez de Larrea et al.
LEUKEMIA (2013)
Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse
Xenofon Papanikolaou et al.
LEUKEMIA & LYMPHOMA (2013)
Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases
Leo Rasche et al.
ANNALS OF HEMATOLOGY (2012)
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: A retrospective survey of 50 patients
Alessandro Gozzetti et al.
CANCER (2012)
Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents
Saad Z. Usmani et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach
Joan Blade et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma
K. Detweiler Short et al.
LEUKEMIA (2011)
Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients
M. Varettoni et al.
ANNALS OF ONCOLOGY (2010)
P53 deletion may drive the clinical evolution and treatment response in multiple myeloma
Lucia Lopez-Anglada et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?
E. Katodritou et al.
LEUKEMIA RESEARCH (2009)
p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma
Neil Sheth et al.
LEUKEMIA RESEARCH (2009)
Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions
H Chang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Share Paper
